View all studies | Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

If you suffer from moderate to severe COPD and are currently taking medications for this condition, then one of our clinical trials may be suitable for you. 

We are evaluating an investigational medication for the treatment of adults with COPD. 

Eligible participants may: 

  • Receive regular monitoring at trial visits and access to our medical team if needed.
  • Help future generations with new treatments by contributing to medical research.
  • Have the results of any additional investigations undertaken with the results also forwarded to their GP.


For further information and to discuss your eligibility with our team, please complete our online form.

Register your interest


When you register your interest with Accellacare (which is part of ICON plc), our team will review your information and connect you with studies that you may be eligible for. When we find a match, Accellacare clinical research specialists will contact you directly for further pre-screening. Please see our Privacy Policy for further details.


Data Protection

ICON plc is the data controller of the personal data, including health data, you choose to provide. We rely on your consent to use this information to identify potentially appropriate clinical trials for you and contact you about them. When we call you for further pre-screening, note that these calls will be recorded.

Please enter the security code:


Please note: You may or may not benefit medically from taking part and you are able to opt-out at any time and do not have to give us a reason for doing so. Your GP will be informed about your participation and all medical assessments that will be carried out as part of the trial. If during screening any abnormal results are found, you and your GP will also be informed.